Efficacy and safety of a 14-day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study

After three treatment failures, Helicobacter pylori infection is deemed refractory as antibiotic treatment options become significantly limited. This study evaluated the efficacy and safety of a 14-day modified concomitant therapy for managing refractory H. pylori infection. Patients who had failed...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gastroenterology and hepatology 2023-12, Vol.38 (12), p.2097-2103
Hauptverfasser:	Zeng, Shu-Yan, Wang, Juan, Liu, Jing, Lin, Min-Juan, Lin, Bo-Shen, Ding, Yu-Ming, Kong, Qing-Zhou, Zhang, Wen-Lin, Duan, Miao, Han, Zhong-Xue, Li, Yue-Yue, Zuo, Xiu-Li, Li, Yan-Qing
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Amoxicillin Antibiotic resistance Antibiotics Clarithromycin Eradication Furazolidone Helicobacter pylori Infections Levofloxacin Metronidazole Omeprazole
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!